DIAG IM3 - Page 102

KRUUSE Equine Equipment VersaTron Focused Shockwave System A non-invasive therapy using high-energy sound waves to treat soft tissue and bone injuries resulting in pain and lameness in horses and dogs. Equine indications for the treatment of musculoskeletal disorders that cause chronic pain and lameness in horses Tendon and Ligament: Bone: Suspensory Ligament Tendonitis or Tenosynovitis Tendon Avulsion and Avulsion Fractures Plantar Tarsal Ligament Desmitis Interosseous Ligament Tears Sesamoiditis Navicular Syndrome Stable Stress Fractures Periostitis Proximal Splint Bone Fractures Bone Cysts (Distal condyle of Cannon) Degenerative Joint Disease: Back: Hock Degenerative Joint Disease Carpitis Ringbone Kissing Spines Lumbosacral Sacroiliac Other: • Muscle Strains • Chronic Wounds Is proven effective with more than a decade of clinical research validating efficacy. Used at more universities and clinics worldwide The only True Focal Shockwave system on the market The VersaTron comes with 4 trodes for various penetration depths: | 17 - 102 5 mm (0 – 25 mm) – Tendons/Suspensor Ligaments/Feet/Wounds 20 mm (0 – 40 mm) – Suspensor Ligaments/Feet 35 mm (15 – 55 mm) – Backs, Pelvic Joint 80 mm (50 – 110 mm) – Sacro-lliac area/Backs with red tip and longer cable lengths to reach higher locations. It is important that the treatment is prescribed by a licenced veterinarian who has an in-depth knowledge of equine anatomy and physiology. A full orthopaedic and neurological work-up should be performed before a VersaTron treatment is planned. Without a proper diagnosis the outcomes of the ESWT treatment may not be satisfactory. While some horse will tolerate ESWT without sedation, restraint and pain management should be considered for both the benefit of the patient and the safety of the practitioners. Since the treatment only takes a few minutes, a short acting sedative/aesthetic may be used as preferred by the veterinarian. Shockwave Due to a period of analgesia it is important the patient performs only light activity following treatment for approximately one week, but most importantly over the 2-3 days following ESWT administration.